AQB-83550-93754 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-30
Dose 1 — Pfizer-BioNTech
2021-03-31
Registered in v-safe
2021-03-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-04-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-03
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-06
Health check-in — day 7, dose 1
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-04-13
Survey response — day 14, dose 1
MedDRA: Injection site rash, Rash — Feeling: Fair

Free text: Rash, starting from injection site, now over arms & neck

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-20
Dose 2 — Pfizer-BioNTech
2021-04-20
Survey response — day 0, dose 2
MedDRA: Erythema, Pruritus, Rash, Rash pruritic, Urticaria, Vascular rupture, Venous haemorrhage — Feeling: Fair · Rash, not including the immediate area around the injection site

Free text: Rash started approx 1.5 weeks ago, across neck/arms/chest. Itchy, red hives, burst blood vessels

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-21
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection site

Adult check-in
2021-04-22
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-04-24
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-20
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-27
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-06-01
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-21
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-21
Survey response — 6 months, dose 2
MedDRA: Rash — Feeling: Good

Free text: Rash

MedDRA releases: 2024-11 · check-in free text available
2021-12-17
Dose 3 — Pfizer-BioNTech
2022-04-20
Survey response — 12 months, dose 2
MedDRA: Achlorhydria, Asthenia, Disturbance in attention, Gastrointestinal disorder, Lethargy, Menstruation irregular — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: GI issues (hypochlorrydia, intestinal permeability) Irregular menses Difficulty maintaining focus/energy (lethargic)

MedDRA releases: 2024-11 · check-in free text available
2022-04-20
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-04-22
Call successful
Participant prefers to complete VAERS report online
2022-06-19
Survey response — 6 months, dose 3
MedDRA: Chest discomfort, Cough, Dyspnoea, Fatigue, Myalgia, Pyrexia, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Cough, shortness of breath, muscle ache, fatigue, chest tightness, fever, runny nose

MedDRA releases: 2024-11 · check-in free text available
2022-06-19
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-06-21
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-30	Pfizer-BioNTech
2	2021-04-20	Pfizer-BioNTech
3	2021-12-17	Pfizer-BioNTech	No

Call center

2 call center cases

1 successful · 1 unsuccessful

See the call center timeline

Free text

Release 7 — day 14, dose 1

2021-04-13

Symptoms: Rash, starting from injection site, now over arms & neck

Release 7 — day 0, dose 2

2021-04-20

Systemic reaction (other): Rash started approx 1.5 weeks ago, across neck/arms/chest. Itchy, red hives, burst blood vessels

Release 10 — 6 months, dose 2

2021-10-21

Symptoms: Rash

Release 11 — 12 months, dose 2

2022-04-20

Symptoms: GI issues (hypochlorrydia, intestinal permeability) Irregular menses Difficulty maintaining focus/energy (lethargic)

Release 12 — 6 months, dose 3

2022-06-19

Symptoms: Cough, shortness of breath, muscle ache, fatigue, chest tightness, fever, runny nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Achlorhydria	·	·	✓
SD	Asthenia	·	·	✓
SD	Chest discomfort	·	·	✓
SD	Cough	·	·	✓
SD	Disturbance in attention	·	·	✓
SD	Dyspnoea	·	·	✓
SD	Fatigue	·	·	✓
SD	Gastrointestinal disorder	·	·	✓
SD	Injection site rash	✓	✓	✓
SD	Lethargy	·	·	✓
SD	Menstruation irregular	·	·	✓
SD	Myalgia	·	·	✓
SD	Pyrexia	·	·	✓
SD	Rash	✓	✓	✓
SD	Rhinorrhoea	·	·	✓
SRO	Erythema	✓	·	✓
SRO	Pruritus	○	✓	○
SRO	Rash	✓	✓	✓
SRO	Rash pruritic	✓	·	✓
SRO	Urticaria	✓	✓	✓
SRO	Vascular rupture	✓	·	✓
SRO	Venous haemorrhage	○	✓	○

✓ active code · ○ coded but marked inactive · blank = not in that release